Biofrontera Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BFRI research report →
About the company
Biofrontera Inc. , a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.
- CEO
- Hermann Lübbert
- IPO
- 2021
- Employees
- 88
- HQ
- Woburn, MA, US
Price Chart
- Market Cap
- $12.93M
- P/E
- -1.06
- P/S
- 0.30
- P/B
- 1.94
- EV/EBITDA
- -1.43
- Div Yield
- 0.00%
- Gross Margin
- 82.79%
- Op Margin
- -20.64%
- Net Margin
- -25.66%
- ROE
- -476.72%
- ROIC
- -62.07%
- Revenue
- $41.70M · 11.80%
- Net Income
- $-10,536,000 · 40.67%
- EPS
- $-1.04 · 67.70%
- Op Income
- $-9,148,000
- FCF YoY
- -29.36%
- 52W High
- $1.19
- 52W Low
- $0.56
- 50D MA
- $0.98
- 200D MA
- $0.92
- Beta
- 0.82
- Avg Volume
- 219.26K
Get TickerSpark's AI analysis on BFRI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 4, 26 | Weber Kevin Daniel | other | 20,000 |
| Mar 5, 26 | Luebbert Hermann | other | 137,500 |
| Mar 4, 26 | Luebbert Hermann | other | 125,000 |
| Mar 4, 26 | Luebbert Hermann | other | 125,000 |
| Mar 5, 26 | Luebbert Hermann | other | 137,500 |
| Mar 5, 26 | Leffler Eugene Frederick | other | 87,500 |
| Mar 4, 26 | Leffler Eugene Frederick | other | 62,500 |
| Mar 4, 26 | Leffler Eugene Frederick | other | 62,500 |
| Mar 5, 26 | Leffler Eugene Frederick | other | 87,500 |
| Mar 4, 26 | Lanckriet Heikki | other | 20,000 |
Our BFRI coverage
Recent articles, reports, and earnings notes.
No research on BFRI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BFRI report →Similar companies
Peers in the same neighborhood.